Stem cell treatment for pressure sores and some diabetic foot ulcers
Part of Skin clinical trials.
This Phase 1 study tests whether injected stem cells can help wounds heal faster or better. It focuses on people with specific wound types and sizes, and checks safety and wound healing over weekly visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a Stage III pressure ulcer, and the wound is about 5 to 36 cc in volume
- You may also have a Stage 1 or 2 diabetic foot ulcer (any size), but not a more advanced diabetic foot wound
- You’re able to give consent (or have a person who can consent for you)
- You can return for weekly wound check visits
- You cannot be allergic to TISSEEL, Tegaderm, or silicon-containing products
- You should not need special wound surgery or machines right now (negative pressure wound therapy, amputation, or surgery at the wound)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether stem cells taken from fat tissue (after a small procedure) can help heal a long-lasting diabetic foot ulcer. It mainly aims to help ulcers that are limited to soft tissue and have good blood flow to the foot.
This trial tests whether injecting your own fat stem cells into a diabetic foot ulcer can help it heal. It is for people with a specific type of foot sore that hasn't healed after 6 weeks of standard care.
This trial tests whether a stem cell product (Stempeucel®) can improve healing and safety for people with critical limb ischemia caused by peripheral artery disease. It is for patients who cannot have (or have already tried) procedures to reopen blocked leg arteries and who have a leg ulcer and low blood-flow measurements.
This trial tests a new cell treatment for diabetic foot ulcers by injecting special regulatory monocytes (OPM cells) to help heal wounds. It is for patients with mild to moderate ulcers that haven't healed for over a month.
This trial tests whether a stem cell product (Stempeucel®) is safe and effective for people with Buerger’s disease causing critical limb ischemia and foot ulcers. It may help improve healing and blood flow when other options may be limited.
This trial tests a new treatment using stem cell-derived exosomes (tiny particles that help cells communicate) to heal diabetic foot ulcers. It aims to see if this approach is safe and effective for people with diabetic foot.
Hear when a new Pressure Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.